z-logo
open-access-imgOpen Access
Genome Stability Pathways in Head and Neck Cancers
Author(s) -
Glenn Jenkins,
Kenneth J. O’Byrne,
Benedict Panizza,
Derek J. Richard
Publication year - 2013
Publication title -
international journal of genomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.705
H-Index - 24
eISSN - 2314-4378
pISSN - 2314-436X
DOI - 10.1155/2013/464720
Subject(s) - genome instability , head and neck squamous cell carcinoma , biology , malignancy , cancer , cancer research , dna repair , chromosome instability , metastasis , head and neck cancer , malignant transformation , gene , bioinformatics , genetics , dna damage , dna , chromosome
Genomic instability underlies the transformation of host cells toward malignancy, promotes development of invasion and metastasis and shapes the response of established cancer to treatment. In this review, we discuss recent advances in our understanding of genomic stability in squamous cell carcinoma of the head and neck (HNSCC), with an emphasis on DNA repair pathways. HNSCC is characterized by distinct profiles in genome stability between similarly staged cancers that are reflected in risk, treatment response and outcomes. Defective DNA repair generates chromosomal derangement that can cause subsequent alterations in gene expression, and is a hallmark of progression toward carcinoma. Variable functionality of an increasing spectrum of repair gene polymorphisms is associated with increased cancer risk, while aetiological factors such as human papillomavirus, tobacco and alcohol induce significantly different behaviour in induced malignancy, underpinned by differences in genomic stability. Targeted inhibition of signalling receptors has proven to be a clinically-validated therapy, and protein expression of other DNA repair and signalling molecules associated with cancer behaviour could potentially provide a more refined clinical model for prognosis and treatment prediction. Development and expansion of current genomic stability models is furthering our understanding of HNSCC pathophysiology and uncovering new, promising treatment strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom